Usefulness of procalcitonin for diagnosing infection in critically ill patients with liver cirrhosis;Utilidad de la procalcitonina para el diagnóstico de infección en el paciente crítico con cirrosis hepática

Medicina Intensiva

Volumn 40, Issue 2, 2016, Pages 84-89

  Villarreal, E ^a   Vacacela, K ^a   Gordon, M ^a   Calabuig, C ^a   Alonso, R ^a   Ruiz, J ^a   Kot, P ^a   Babiloni, D ^a   Ramirez P ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Infection; Liver cirrhosis; Peritonitis; Procalcitonin

Indexed keywords

PROCALCITONIN; CALCITONIN;

ABDOMINAL INFECTION; ARTICLE; BACTEREMIA; CHILD PUGH SCORE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY RATE; PNEUMONIA; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BACTERIAL INFECTIONS; BLOOD; COMPLICATION; CRITICAL ILLNESS;

BACTERIAL INFECTIONS; CALCITONIN; CRITICAL ILLNESS; HUMANS; INTENSIVE CARE UNITS; LIVER CIRRHOSIS; RETROSPECTIVE STUDIES;

EID: 84926165379     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2015.02.006     Document Type: Article

References (31)

1. Carly W.R., Strauss E. A prospective study of bacterial infections in pacients with cirrhosis. J Hepatol 1993, 18:353-358.
2. Almeida J., Galhenage S., Yu J., Kurtovic J., Riordan S.M. Gut flora and bacterial translocation in chronic liver disease. Worl J Gastroenterology. 2006, 14:1493-1502.
3. Ancel D., Barraud H., Bronowicki J.P. Intestinal permeability and cirrhosis. Gastroenterol Clin Biol 2006, 30:460-468.
4. Palma P., Mihaljevic N., Hasenberg T., Keese M., koeppel T.A. Intestinal barrier dysfunction in developing liver cirrhosis; An in vivo analysis of bacterial traslocation. Hepatol Res 2007, 37:6-12.
5. Guarner G., Soriano G. Bacterial tranlocation and its consequences in patients with cirrhosis. Eur J Gastroenterolg Hepatol 2005, 17:27-31.
6. Preda S., Trifan A., Gîrleanu I., Stanciu C., Cojocariu Infectious complications in patients with liver cirrhosis. CRev Med Chir Soc Med Nat Iasi 2014, 118:590-597.
7. Bruns T., Zimmermann H.W., Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol 2014, 20:2542-2554.
8. Fernández J., Gustot T. Management of bacterial infections in cirrhosis. J Hepatol. 2012, 56(Suppl 1):S1-S12.
9. Pieri G., Agarwal B., Burroughs A.K. C-reactive protein and bacterial infection in cirrhosis. Ann Gastroenterol. 2014, 27:113-120.
10. Nishikura T. Procalcitonin production in a thyroidectomized patient. Intensive Care Med 1999, 25:1031.
11. Meisner M., Muller V., Khakpour Z., Toegel E., Redl H. Induction of procalcitonin and proinflamatory cytokines in an anhepatic baboon endotoxin shock model. Shock 2003, 19:187-190.
12. Peres Bota D., van Nuffelen M., Zakariah A., Vincent J.L. Serum levels of C-reactive protein and procalcitonina in critically ill patients with cirrhosis of the liver. J Lab Clin Med 2005, 146:347-351.
13. Eyraud D., Ayed S.B., Tanguy M.L., Vézinet C., Siksik J.M., Bernard M., et al. Procalcitonin in liver transplantation: are high levels due to donors or recipients?. Crit Care 2008, 12:85-92.
14. Lin K.H., Wang F.L., Wu M.S., Jiang B.Y., Kao W.L., Chao H.Y., et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis. Diagn Microbiol Infect Dis. 2014 Sep, 80:72-78.
15. Garner J.S., Jarvis W.R., Emori T.G. CDC definitions for nosocomial infections. Am J Infect Control 1988, 16:128-140.
16. García de Guadiana-Romualdo L.M., Rebollo-Acebes S., Esteban-Torrella P., Jiménez-Sánchez R., Hernando-Holgado A., Ortín-Freire A., et al. Prognostic value of lipopolysaccharide binding protein and procalcitonin in patients with severe sepsis and septic shock admitted to intensive care. Med Intensiva. 2014.
17. Husová L., Husa P., Senkyrík M., Lata J. Procalcitonin as a indicator of infectio in patient with liver cirrhosis. Vnitr Lek 2004, 50:153-156.
18. Park W.B., Lee K.D., Lee C.S., Jang H.C., Kim H.B., Lee H.S., et al. Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis. Diagn Microbiol Infect Dis 2005, 51:227-230.
19. Mackenzie I., Woodhouse J. C-reactive protein concentrations during bacteraemia: A comparision between patients with and without liver dysfunction. Intensive Care Med 2006, 32:1344-1351.
20. Morgenthaler N.G., Struck J., Chancerelle Y., Weglohner W., Agay D., Bohuon C. Production of procalcitonin in non-throidal tissue after LPS injection. Horm Metab Res 2003, 35:290-295.
21. Meisner M., Müller V., Khakpoor Z., Toegel E., Redl H. Induction of procalcitonina and proinflammatory cytokines in an anhepatic baboon endotoxin shock model. Shock 2003, 19:187-190.
22. Connert S., Stremmel W., Elsing C. Procalcitonin is a valid marker of infection in descompensated cirrhosis. Z Gastroenterol 2003, 41:165-170.
23. Elefsiniotis I.S., Skounakis M., Vezali E., Pantazis K.D., Petrocheilou A., Pirounaki M. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver Disease. Eur J Gastroenterol Hepatol 2006, 18:525-530.
24. Lazzarotto C., Ronsoni M.F., Fayad L., Nogueira C.L., Bazzo M.L., Narciso-Schiavon J.L., et al. Acute phase protein for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosis. Annals of Hepatology 2013, 12:431-439.
25. Marciano S., Haddad L., Martínez A.P., Posadas M.L., Piñero F., Mora G.J., et al. Ultra-sensitive PCT may help rule out bacterial infections in patients with cirrhosis. Annals of Hepatology 2014, 13:541-547.
26. Li C.H., Yang R.B., Pang J.H., Chan S.S., Lin C.C., Chen C.H., et al. Procalcitonin as iomarker for bacterial infection in patients with liver cirrhosis in the emergeny department. Acad Emerg Med 2011, 18:122.
27. Bota D.P., Van Nuffeelen M., Zakariah A.N., Vincent J.L. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med 2005, 146:347-351.
28. Spahr L., Morard I., Hadenque A., Vadas L., Pugin J. Procalcitonin is no an accurate marker of spontaneous bacterial peritonitis in patients with cirrhosis. Hepatogastroenterol 2001, 48:502-505.
29. Yank S.K., Xiao L., Zhang H., Xu X.X., Song P.A., Liu F.Y., et al. Significance of serum procalcitonin as biomarker for detection of bacterial peritonitis: a systematic review and meta-analysis. BMC Infectious Dis 2014, 14:452.
30. Faisal M., Emmet B. Liver biopsy for histological assessment-the case against. Saudi J Gastroenterol 2010, 16:124-132.
31. Stauber R., Lackner C. Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C. World J Gastroenterol 2007, 13:4287-4294.